China Clinical Access VSRI's focus on clinical research in China and outcomes research worldwide positions them as a gateway for pharma and medical device sponsors seeking China-based execution, regulatory navigation, and high-quality site management. Their collaboration with prestigious institutions and leadership in the CCMR registry can facilitate access to trusted networks and data for global trials.

VitalSystem Advantage VSRI's proprietary health information management system VitalSystem and its EHR driven approach enable efficient data capture, outcomes tracking, and real-world evidence generation, presenting opportunities to offer data integration, analytics services, or ongoing data management for sponsors.

Registry Leadership As a co-founder of the national CCMR cardiometabolic disease registry, VSRI can provide access to registry data, domain expertise, and collaborative opportunities for registry-based studies, health economics analyses, and post-market surveillance.

Biopharma Partnerships VSRI already collaborates with biopharmaceutical and medical device clients, making it a ready-made partner for late-stage trials, real-world evidence studies, observational cohorts, and health outcomes research in China and global settings.

Flexible Growth Partner With a lean team of 11-50 employees and mid-market revenue, VSRI offers cost-effective, scalable collaboration for sponsors that prefer specialized CRO capabilities, fast onboarding, and close partnering without the overhead of large firms.